| 134964-100MG |
|
1194050-23-1 |
[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5S)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-(1-methylethyl)oxazole-κN3]-(+)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
≥98%,99%e.e.
|
100MG |
C35H42IrNOP . C32H12BF24 |
|
|
|
| 134964-25MG |
|
1194050-23-1 |
[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5S)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-(1-methylethyl)oxazole-κN3]-(+)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
≥98%,99%e.e.
|
25MG |
C35H42IrNOP . C32H12BF24 |
|
|
|
| 200215-100MG |
|
944836-22-0 |
(4S)-2-[2-[Bis[4-(trifluoromethyl)phenyl]phosphino]-5-(trifluoromethyl)phenyl]-4-tert-butyl-4,5-dihydrooxazole
≥98%,99%e.e
|
100MG |
C28H23F9NOP |
|
|
|
| 200214-100MG |
|
1006708-91-3 |
(4R)-2-[2-[Bis[4-(trifluoromethyl)phenyl]phosphino]-5-(trifluoromethyl)phenyl]-4-tert-butyl-4,5-dihydrooxazole
≥98%,99%e.e
|
100MG |
C28H23F9NOP |
|
|
|
| 135918-100MG |
|
148461-14-7 |
(4S)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-(1-methylethyl)oxazole
≥95%,-
|
100MG |
C24H24NOP |
|
|
|
| 135919-100MG |
|
164858-78-0 |
(4R)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-(1-methylethyl)oxazole
≥98%,99%e.e.
|
100MG |
C24H24NOP |
|
|
|
| 135922-100MG |
|
148461-16-9 |
(4S)-4-(1,1-Dimethylethyl)-2-[2-(diphenylphosphino)phenyl]-4,5-dihydrooxazole
≥98%,99%e.e.
|
100MG |
C25H26NOP |
|
|
|
| 135923-100MG |
|
164858-79-1 |
(4R)-4-(1,1-Dimethylethyl)-2-[2-(diphenylphosphino)phenyl]-4,5-dihydrooxazole
≥98%,99%e.e.
|
100MG |
C25H26NOP |
|
|
|
| 135924-100MG |
|
148461-13-6 |
(4S)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-(phenylmethyl)oxazole
≥95%,99%e.e.
|
100MG |
C28H24NOP |
|
|
|
| 135925-100MG |
|
314020-70-7 |
(4R)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-(phenylmethyl)oxazole
≥98%,99%e.e.
|
100MG |
C28H24NOP |
|
|
|
| 135920-100MG |
|
148461-15-8 |
(4S)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-phenyloxazole
≥98%,99%e.e.
|
100MG |
C27H22NOP |
|
|
|
| 135921-100MG |
|
167171-03-1 |
(4R)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-phenyloxazole
≥98%,99%e.e.
|
100MG |
C27H22NOP |
|
|
|
| 200189-100MG |
|
503538-70-3 |
1,1'-[(4S)-2,2,2',2'-Tetrafluoro[4,4'-bi-1,3-benzodioxole]-5,5'-diyl]bis[1,1-diphenylphosphine]
≥98%,99%e.e.
|
100MG |
C38H24F4O4P2 |
|
|
|
| 200188-100MG |
|
503538-69-0 |
1,1'-[(4R)-2,2,2',2'-Tetrafluoro[4,4'-bi-1,3-benzodioxole]-5,5'-diyl]bis[1,1-diphenylphosphine]
≥98%,99%e.e.
|
100MG |
C38H24F4O4P2 |
|
|
|
| 200383-100MG |
|
1310054-14-8 |
1,1'-[(1S)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-bis(4-chlorophenyl)phosphine]
≥98%,99%e.e.
|
100MG |
C38H28Cl4O2P2 |
|
|
|
| 200382-100MG |
|
1310054-04-6 |
1,1'-[(1R)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-bis(4-chlorophenyl)phosphine]
≥98%,99%e.e.
|
100MG |
C38H28Cl4O2P2 |
|
|
|
| 200381-100MG |
|
NA |
1,1'-[(1S)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-di-1-naphthalenylphosphine]
≥98%,99%e.e.
|
100MG |
C54H40O2P2 |
|
|
|
| 200380-100MG |
|
NA |
1,1'-[(1R)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-di-1-naphthalenylphosphine]
≥98%,99%e.e.
|
100MG |
C54H40O2P2 |
|
|
|
| 200379-100MG |
|
849239-14-1 |
1,1'-[(1S)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-di-2-naphthalenylphosphine]
≥98%,99%e.e.
|
100MG |
C54H40O2P2 |
|
|
|
| 200378-100MG |
|
256390-46-2 |
1,1'-[(1R)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-di-2-naphthalenylphosphine]
≥98%,99%e.e.
|
100MG |
C54H40O2P2 |
|
|
|
